cimadronate has been researched along with Peritoneal Carcinomatosis in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Iguchi, H; Ikeda, M; Inoue, K; Kataoka, Y; Matsusue, K; Nishino, Y; Nishiyama, K; Takiguchi, S | 1 |
1 other study(ies) available for cimadronate and Peritoneal Carcinomatosis
Article | Year |
---|---|
The bisphosphonate incadronate inhibits intraperitoneal dissemination in an in vivo pancreatic cancer model.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Diphosphonates; Dose-Response Relationship, Drug; Enzyme Activation; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Pancreatic Neoplasms; Peritoneal Neoplasms; rho-Associated Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2012 |